Literature DB >> 1992478

Homologous recombination in Leishmania enriettii.

J F Tobin1, A Laban, D F Wirth.   

Abstract

We have used derivatives of the recently developed stable transfection vector pALT-Neo to formally demonstrate that Leishmania enriettii contains the enzymatic machinery necessary for homologous recombination. This observation has implications for gene regulation, gene amplification, genetic diversity, and the maintenance of tandemly repeated gene families in the Leishmania genome as well as in closely related organisms, including Trypanosoma brucei. Two plasmids containing nonoverlapping deletions of the chloramphenicol acetyltransferase (CAT) gene, as well as the neomycin-resistance gene, were cotransfected into L. enriettii. Analysis of the DNA from these cells by Southern blotting and plasmid rescue revealed that a full-length or doubly deleted CAT gene could be reconstructed by homologous crossing-over and/or gene conversion between the two deletion plasmids. Additionally, parasites cotransfected with pALT-Neo and pALT-CAT-S, a plasmid containing two copies of the chimeric alpha-tubulin-CAT gene, resulted in G418-resistant parasites expressing high levels of CAT activity. The structure of the DNA within these cells, as shown by Southern blot analysis and the polymerase chain reaction, is that which would be expected from a homologous exchange event occurring between the two plasmids.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1992478      PMCID: PMC50914          DOI: 10.1073/pnas.88.3.864

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  Unequal crossover and the evolution of multigene families.

Authors:  G P Smith
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1974

2.  Sequence complexity of circular Epstein-Bar virus DNA in transformed cells.

Authors:  B E Griffin; E Björck; G Bjursell; T Lindahl
Journal:  J Virol       Date:  1981-10       Impact factor: 5.103

3.  Nucleotide sequence and exact localization of the neomycin phosphotransferase gene from transposon Tn5.

Authors:  E Beck; G Ludwig; E A Auerswald; B Reiss; H Schaller
Journal:  Gene       Date:  1982-10       Impact factor: 3.688

4.  Tandem arrangement of tubulin genes in the protozoan parasite Leishmania enriettii.

Authors:  S M Landfear; D McMahon-Pratt; D F Wirth
Journal:  Mol Cell Biol       Date:  1983-06       Impact factor: 4.272

5.  Unstable DNA amplifications in methotrexate-resistant Leishmania consist of extrachromosomal circles which relocalize during stabilization.

Authors:  S M Beverley; J A Coderre; D V Santi; R T Schimke
Journal:  Cell       Date:  1984-09       Impact factor: 41.582

6.  Overproduction of a bifunctional thymidylate synthetase-dihydrofolate reductase and DNA amplification in methotrexate-resistant Leishmania tropica.

Authors:  J A Coderre; S M Beverley; R T Schimke; D V Santi
Journal:  Proc Natl Acad Sci U S A       Date:  1983-04       Impact factor: 11.205

7.  Homologous recombination between plasmids in mammalian cells can be enhanced by treatment of input DNA.

Authors:  R S Kucherlapati; E M Eves; K Y Song; B S Morse; O Smithies
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

8.  Control of tubulin gene expression in the parasitic protozoan Leishmania enriettii.

Authors:  S M Landfear; D F Wirth
Journal:  Nature       Date:  1984 Jun 21-27       Impact factor: 49.962

9.  Stable expression of the bacterial neor gene in Leishmania enriettii.

Authors:  A Laban; J F Tobin; M A Curotto de Lafaille; D F Wirth
Journal:  Nature       Date:  1990-02-08       Impact factor: 49.962

10.  Trypanosome mRNAs share a common 5' spliced leader sequence.

Authors:  M Parsons; R G Nelson; K P Watkins; N Agabian
Journal:  Cell       Date:  1984-08       Impact factor: 41.582

View more
  8 in total

1.  Stable molecular transformation of Toxoplasma gondii: a selectable dihydrofolate reductase-thymidylate synthase marker based on drug-resistance mutations in malaria.

Authors:  R G Donald; D S Roos
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

2.  Parameters controlling the rate of gene targeting frequency in the protozoan parasite Leishmania.

Authors:  B Papadopoulou; C Dumas
Journal:  Nucleic Acids Res       Date:  1997-11-01       Impact factor: 16.971

3.  A shuttle vector which facilitates the expression of transfected genes in Trypanosoma cruzi and Leishmania.

Authors:  J M Kelly; H M Ward; M A Miles; G Kendall
Journal:  Nucleic Acids Res       Date:  1992-08-11       Impact factor: 16.971

4.  Isolation of virulence genes directing surface glycosyl-phosphatidylinositol synthesis by functional complementation of Leishmania.

Authors:  K A Ryan; L A Garraway; A Descoteaux; S J Turco; S M Beverley
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-15       Impact factor: 11.205

5.  Amplification of an alternate transporter gene suppresses the avirulent phenotype of glucose transporter null mutants in Leishmania mexicana.

Authors:  Xiuhong Feng; Dayana Rodriguez-Contreras; Cosmo Buffalo; H G Archie Bouwer; Elizabeth Kruvand; Stephen M Beverley; Scott M Landfear
Journal:  Mol Microbiol       Date:  2008-11-10       Impact factor: 3.501

Review 6.  Genetically modified organisms and visceral leishmaniasis.

Authors:  Rudra Chhajer; Nahid Ali
Journal:  Front Immunol       Date:  2014-05-14       Impact factor: 7.561

7.  Single-Strand Annealing Plays a Major Role in Double-Strand DNA Break Repair following CRISPR-Cas9 Cleavage in Leishmania.

Authors:  Wen-Wei Zhang; Greg Matlashewski
Journal:  mSphere       Date:  2019-08-21       Impact factor: 4.389

8.  Application of CRISPR/Cas9-Based Reverse Genetics in Leishmania braziliensis: Conserved Roles for HSP100 and HSP23.

Authors:  Vanessa Adaui; Constanze Kröber-Boncardo; Christine Brinker; Henner Zirpel; Julie Sellau; Jorge Arévalo; Jean-Claude Dujardin; Joachim Clos
Journal:  Genes (Basel)       Date:  2020-09-30       Impact factor: 4.096

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.